Searched for: Department/Unit:Otolaryngology
Oropharyngeal cancer: current understanding and management
Cohan, David M; Popat, Saurin; Kaplan, Seth E; Rigual, Nestor; Loree, Thom; Hicks, Wesley L Jr
PURPOSE OF REVIEW: The goals of this article are: to briefly review oropharyngeal anatomy; to provide a review of the epidemiology of oropharyngeal cancer in the Western Hemisphere; to review the literature on the association of human papilloma virus with oropharyngeal cancer; to review the recent literature on evolving diagnostic techniques for oropharyngeal cancer; and to summarize accepted management strategies for oropharyngeal cancer by subsite. RECENT FINDINGS: The incidence of oropharyngeal cancer may be increasing among younger age groups in the Western Hemisphere, and this may be related to an increased association with human papillomavirus 16. The implications of this viral association with regard to outcomes and management strategies remain under investigation. Screening with toluidine blue, autofluorescence, or both may be useful adjuncts to physical examination and panendoscopy in assessing potentially invasive or dysplastic lesions of the oropharynx. These techniques remain under study. MRI and PET scan are proving to be useful techniques for assessing local extension, regional metastases, and recurrences of squamous cell carcinoma (SCC) of the oropharynx in selected cases. However, serial computed tomography scanning remains the imaging modality of choice in the United States. Early SCCs of the oropharynx (T1-2), in general, may be managed effectively with either surgery or primary irradiation, though, with either technique, clinicians must have a management plan for the neck. Advanced SCCs of the oropharynx (T3-4, nodally aggressive, or both) require multimodal approaches consisting of either surgery along with adjuvant irradiation or concurrent chemoradiation along with salvage surgery (as necessary). SUMMARY: Management of SCC of the oropharynx is in a period of transition because of evolving changes in our understanding of the oncogenic process; evolving diagnostic techniques; and evolving combinations of therapies, both surgical and nonsurgical. For the time being, we propose using local subsite and disease stage to guide therapeutic decision-making.
PMID: 19373958
ISSN: 1531-6998
CID: 2332952
Septoplasty complications: avoidance and management
Bloom, Jason D; Kaplan, Seth E; Bleier, Benjamin S; Goldstein, Stephen A
Nasal obstruction from a deviated septum is one of the more frequent complaints bringing patients into an otolaryngology office. Despite the significant number of septoplasties performed each year, complications after this procedure are relatively uncommon. Most complications result from inadequate surgical planning or poor technique and often can be prevented. Surgeons should discuss these risks with patients before surgery as part of the informed consent process. This article reviews how complications of septoplasty can occur, compromising the functional and aesthetic aspects of a patient's life, and how attention to detail can reduce the risk for these complications. The septoplasty surgeon must be aware of all the possible complications that may arise so as to convey the benefits and risks of surgery effectively to prospective patients.
PMID: 19486742
ISSN: 1557-8259
CID: 2332942
Oncogenesis and Molecular Targeted Therapy in Thyroid Cancer
Chapter by: Patel, KN; Singh, B
in: A Practical Manual of Thyroid and Parathyroid Disease by
pp. 87-103
ISBN: 9781444307641
CID: 2292752
Atypical speech abnormality following initiation of deep brain stimulation of the subthalamic nucleus (STN-DBS) for Parkinson's disease (PD) [Meeting Abstract]
Gupta, F; Cho, C; Sidtis, D; Sidtis, JJ; Alterman, RL; Tagliati, M
ISI:000266618101633
ISSN: 0885-3185
CID: 2243682
Repair of the vestibular system via adenovector delivery of Atoh1: a potential treatment for balance disorders
Baker, Kim; Brough, Douglas E; Staecker, Hinrich
Loss of auditory and vestibular hair cells is a common cause of hearing loss and balance disorders. A variety of strategies have been proposed to restore function to damaged inner ear neuroepithelium. Delivery of the atonal homolog, atoh1, has been demonstrated to induce recovery of auditory and vestibular hair cells using a variety of delivery methods and model systems. We have developed a mouse model of vestibular aminoglycoside ototoxicity and demonstrated that delivery of an advanced generation adenovector that expresses atoh1 results in the regeneration of vestibular hair cells. Additionally, mice treated with atoh1 recover balance function. Currently vestibular diseases have few treatment options and several lines of evidence suggest that regeneration of hair cells may be more easily accomplished in the vestibular system. Development of atoh1-based gene therapy for vestibular hair cell loss may provide an initial opportunity for developing gene therapy for inner ear disease.
PMID: 19494572
ISSN: 0065-3071
CID: 2184212
Pearls in facelift management
Zimbler, Marc S; Mashkevich, Grigoriy
Facelift surgery is complex and requires a significant commitment from both patient and surgeon. This article provides a collection of surgical tips and pearls that can be applied to most facelift procedures, no matter the surgical technique. A holistic approach to patient care is discussed regarding preoperative, perioperative, and postoperative management. Within this article the authors outline details so facial plastic surgeons can provide their patients with the smoothest surgical experience and recovery.
PMID: 19900667
ISSN: 1558-1926
CID: 2064972
Nociceptive sensitization by endothelin-1
Hans, Guy; Schmidt, Brian L; Strichartz, Gary
The endogenous peptide endothelin-1 (ET-1), originally identified as a potent vasoconstrictor, plays a role in a number of painful conditions. In this review article we discuss the mechanisms that are essential for local sensitization by subcutaneously administered ET-1, and report evidence of ET-1's ability to sensitize distant regions of the body, through the central nervous system and, likely, coupling through the spinal cord. In addition, we will review the latest information on the role of ET-1 in cancerous and non-cancerous conditions. Cancer pain has indeed been shown to be attenuated by antagonists of endothelin receptors, and ET-1 is known to be secreted by cancer cells of many different histologic types. Furthermore, a growing body of evidence links increased expression and secretion of ET-1 to the occurrence of non-cancer related pain syndromes, such as inflammatory and neuropathic pain syndromes.
PMID: 19150466
ISSN: 1872-6321
CID: 1648512
Hypereosinophilia in Two Patients with Ventriculoperitoneal Shunts [Meeting Abstract]
Gagliardo, C; Herzog, R; Bostwick, S; Lighvani, S
ISI:000263596301441
ISSN: 0091-6749
CID: 1529172
RECURRENT OTITIS MEDIA AND 22Q11.2 MICRO DELETION [Meeting Abstract]
Camacho-Halili, M; Herzog, R
ISI:000271913500235
ISSN: 1081-1206
CID: 1529162
Micro Duplication Of Chromosome 14, Recurrent [Meeting Abstract]
Camacho-Halili, M; DeLaMora, PA; Davis, JG; Herzog, Ronit
ORIGINAL:0009650
ISSN: 1081-1206
CID: 1529482